BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 15469392)

  • 21. Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events.
    Quintanilla-Martinez L; Kremer M; Specht K; Calzada-Wack J; Nathrath M; Schaich R; Höfler H; Fend F
    Am J Pathol; 2003 May; 162(5):1449-61. PubMed ID: 12707028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JAK/STAT-dependent gene regulation by cytokines.
    Hebenstreit D; Horejs-Hoeck J; Duschl A
    Drug News Perspect; 2005 May; 18(4):243-9. PubMed ID: 16034480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STAT proteins: from normal control of cellular events to tumorigenesis.
    Calò V; Migliavacca M; Bazan V; Macaluso M; Buscemi M; Gebbia N; Russo A
    J Cell Physiol; 2003 Nov; 197(2):157-68. PubMed ID: 14502555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
    Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STATs in oncogenesis.
    Bowman T; Garcia R; Turkson J; Jove R
    Oncogene; 2000 May; 19(21):2474-88. PubMed ID: 10851046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor.
    Guo D; Dunbar JD; Yang CH; Pfeffer LM; Donner DB
    J Immunol; 1998 Mar; 160(6):2742-50. PubMed ID: 9510175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
    Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
    Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional roles of STAT family proteins: lessons from knockout mice.
    Akira S
    Stem Cells; 1999; 17(3):138-46. PubMed ID: 10342556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral but not central axotomy induces changes in Janus kinases (JAK) and signal transducers and activators of transcription (STAT).
    Schwaiger FW; Hager G; Schmitt AB; Horvat A; Hager G; Streif R; Spitzer C; Gamal S; Breuer S; Brook GA; Nacimiento W; Kreutzberg GW
    Eur J Neurosci; 2000 Apr; 12(4):1165-76. PubMed ID: 10762348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription.
    Catlett-Falcone R; Dalton WS; Jove R
    Curr Opin Oncol; 1999 Nov; 11(6):490-6. PubMed ID: 10550013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T; Ma J; Cao X
    Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting transcription factors for cancer therapy.
    Redell MS; Tweardy DJ
    Curr Pharm Des; 2005; 11(22):2873-87. PubMed ID: 16101443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunolocalisation of the janus kinases (JAK)--signal transducers and activators of transcription (STAT) pathway in human epidermis.
    Nishio H; Matsui K; Tsuji H; Tamura A; Suzuki K
    J Anat; 2001 May; 198(Pt 5):581-9. PubMed ID: 11430697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
    Garcia R; Yu CL; Hudnall A; Catlett R; Nelson KL; Smithgall T; Fujita DJ; Ethier SP; Jove R
    Cell Growth Differ; 1997 Dec; 8(12):1267-76. PubMed ID: 9419415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Getting the message across, STAT! Design principles of a molecular signaling circuit.
    Vinkemeier U
    J Cell Biol; 2004 Oct; 167(2):197-201. PubMed ID: 15504906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of STATs in inflammation and inflammatory diseases.
    Pfitzner E; Kliem S; Baus D; Litterst CM
    Curr Pharm Des; 2004; 10(23):2839-50. PubMed ID: 15379672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas.
    Mitchell TJ; John S
    Immunology; 2005 Mar; 114(3):301-12. PubMed ID: 15720432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development.
    Bromberg J
    Breast Cancer Res; 2000; 2(2):86-90. PubMed ID: 11250696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles and regulation of stat family transcription factors in human breast cancer.
    Clevenger CV
    Am J Pathol; 2004 Nov; 165(5):1449-60. PubMed ID: 15509516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.